Literature DB >> 23262638

Toxicant-associated steatohepatitis.

Banrida Wahlang1, Juliane I Beier, Heather B Clair, Heather J Bellis-Jones, K Cameron Falkner, Craig J McClain, Matt C Cave.   

Abstract

Hepatotoxicity is the most common organ injury due to occupational and environmental exposures to industrial chemicals. A wide range of liver pathologies ranging from necrosis to cancer have been observed following chemical exposures both in humans and in animal models. Toxicant-associated fatty liver disease (TAFLD) is a recently named form of liver injury pathologically similar to alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD). Toxicant-associated steatohepatitis (TASH) is a more severe form of TAFLD characterized by hepatic steatosis, inflammatory infiltrate, and in some cases, fibrosis. While subjects with TASH have exposures to industrial chemicals, such as vinyl chloride, they do not have traditional risk factors for fatty liver such as significant alcohol consumption or obesity. Conventional biomarkers of hepatotoxicity including serum alanine aminotransferase activity may be normal in TASH, making screening problematic. This article examines selected chemical exposures associated with TAFLD in human subjects or animal models and concisely reviews the closely related NAFLD and ALD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23262638      PMCID: PMC5114851          DOI: 10.1177/0192623312468517

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  154 in total

1.  Mercury, chronic hepatitis and hepatoma.

Authors:  Viroj Wiwnaitkit; Kamon Chaiyasit
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-11-10       Impact factor: 2.947

2.  An epidemiological study with risk analysis of liver diseases in the general population living in a methyl mercury polluted area.

Authors:  M Futatsuka; T Kitano; M Nagano; T Inaoka; Y Arimatsu; T Ueno; J Wakamiya; K Miyamoto
Journal:  J Epidemiol Community Health       Date:  1992-06       Impact factor: 3.710

Review 3.  Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.

Authors:  J Aubert; K Begriche; L Knockaert; M A Robin; B Fromenty
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-06-12       Impact factor: 2.947

Review 4.  Ethanol metabolism, cirrhosis and alcoholism.

Authors:  C S Lieber
Journal:  Clin Chim Acta       Date:  1997-01-03       Impact factor: 3.786

5.  Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.

Authors:  Irina A Kirpich; Leila N Gobejishvili; Marjorie Bon Homme; Sabine Waigel; Matt Cave; Gavin Arteel; Shirish S Barve; Craig J McClain; Ion V Deaciuc
Journal:  J Nutr Biochem       Date:  2010-03-20       Impact factor: 6.048

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.

Authors:  Michelle M Angrish; A D Jones; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2011-09-02       Impact factor: 4.849

8.  Liver fibrosis in asymptomatic polyvinyl chloride workers.

Authors:  Tun-Jen Hsiao; Jung-Der Wang; Pei-Ming Yang; Pei-Cheng Yang; Tsun-Jen Cheng
Journal:  J Occup Environ Med       Date:  2004-09       Impact factor: 2.162

9.  Acute effects of 2-nitropropane on rat liver and brain.

Authors:  A Zitting; H Savolainen; J Nickels
Journal:  Toxicol Lett       Date:  1981-11       Impact factor: 4.372

10.  Examination of the relationships between environmental exposures to volatile organic compounds and biochemical liver tests: application of canonical correlation analysis.

Authors:  Jing Liu; Wanzer Drane; Xuefeng Liu; Tiejian Wu
Journal:  Environ Res       Date:  2008-12-30       Impact factor: 6.498

View more
  74 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.

Authors:  Josiah E Hardesty; Banrida Wahlang; K Cameron Falkner; Hongxue Shi; Jian Jin; Yun Zhou; Daniel W Wilkey; Michael L Merchant; Corey T Watson; Wenke Feng; Andrew J Morris; Bernhard Hennig; Russell A Prough; Matthew C Cave
Journal:  J Proteome Res       Date:  2019-03-15       Impact factor: 4.466

3.  Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Toxicol Environ Chem       Date:  2020-05-22       Impact factor: 1.437

Review 4.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

Review 5.  Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases.

Authors:  Angela C Cheung; Douglas I Walker; Brian D Juran; Gary W Miller; Konstantinos N Lazaridis
Journal:  Hepatology       Date:  2019-12-24       Impact factor: 17.425

6.  Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.

Authors:  Kritika Karri; David J Waxman
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

7.  Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.

Authors:  Xiang Zhang; Walter H Watson; Xue Shi; Xiaoli Wei; Imhoi Koo; Robin H Schmidt; Xinmin Yin; Seong Ho Kim; Andrew Vaughn; Craig J McClain; Gavin E Arteel
Journal:  J Proteome Res       Date:  2013-12-17       Impact factor: 4.466

8.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

9.  Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice.

Authors:  Lisanne C Anders; Heegook Yeo; Brenna R Kaelin; Anna L Lang; Adrienne M Bushau; Amanda N Douglas; Matt Cave; Gavin E Arteel; Craig J McClain; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-28       Impact factor: 4.219

10.  Polychlorinated Biphenyl-Xenobiotic Nuclear Receptor Interactions Regulate Energy Metabolism, Behavior, and Inflammation in Non-alcoholic-Steatohepatitis.

Authors:  Banrida Wahlang; Russell A Prough; K Cameron Falkner; Josiah E Hardesty; Ming Song; Heather B Clair; Barbara J Clark; J Christopher States; Gavin E Arteel; Matthew C Cave
Journal:  Toxicol Sci       Date:  2015-11-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.